Accelerate Diagnostics, Inc. (AXDX)
USD 0.64
(-7.51%)
USD 0.64
(-7.51%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 12.05 Million USD | -5.43% |
| 2022 | 12.75 Million USD | 8.23% |
| 2021 | 11.78 Million USD | 5.53% |
| 2020 | 11.16 Million USD | 20.09% |
| 2019 | 9.29 Million USD | 63.97% |
| 2018 | 5.67 Million USD | 35.74% |
| 2017 | 4.17 Million USD | 1597.97% |
| 2016 | 246 Thousand USD | 67.35% |
| 2015 | 147 Thousand USD | 20.49% |
| 2014 | 122 Thousand USD | 152.67% |
| 2013 | 48.28 Thousand USD | -79.54% |
| 2012 | 236 Thousand USD | -78.95% |
| 2011 | 1.12 Million USD | -50.07% |
| 2010 | 2.24 Million USD | 76.84% |
| 2009 | 1.26 Million USD | 167.05% |
| 2008 | 475.52 Thousand USD | 159.66% |
| 2007 | 183.13 Thousand USD | -13.9% |
| 2006 | 212.7 Thousand USD | -57.64% |
| 2005 | 502.11 Thousand USD | 323.31% |
| 2004 | 118.61 Thousand USD | -86.05% |
| 2003 | 850.57 Thousand USD | 30.06% |
| 2002 | 653.97 Thousand USD | -23.57% |
| 2001 | 855.66 Thousand USD | -45.41% |
| 2000 | 1.56 Million USD | -45.91% |
| 1999 | 2.89 Million USD | -60.74% |
| 1998 | 7.38 Million USD | 195.26% |
| 1997 | 2.5 Million USD | 19.05% |
| 1996 | 2.1 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 2.92 Million USD | -2.63% |
| 2024 Q2 | 2.98 Million USD | 2.23% |
| 2023 FY | 12.05 Million USD | -5.43% |
| 2023 Q1 | 2.81 Million USD | -5.38% |
| 2023 Q3 | 3.29 Million USD | 12.94% |
| 2023 Q4 | 3 Million USD | -9.06% |
| 2023 Q2 | 2.92 Million USD | 3.88% |
| 2022 FY | 12.75 Million USD | 8.23% |
| 2022 Q4 | 2.97 Million USD | 0.41% |
| 2022 Q3 | 2.96 Million USD | -23.34% |
| 2022 Q1 | 2.95 Million USD | -11.52% |
| 2022 Q2 | 3.86 Million USD | 30.53% |
| 2021 Q1 | 2.51 Million USD | -19.01% |
| 2021 FY | 11.78 Million USD | 5.53% |
| 2021 Q2 | 2.79 Million USD | 11.12% |
| 2021 Q4 | 3.34 Million USD | 7.08% |
| 2021 Q3 | 3.12 Million USD | 11.58% |
| 2020 Q3 | 3.58 Million USD | 68.85% |
| 2020 Q4 | 3.1 Million USD | -13.35% |
| 2020 FY | 11.16 Million USD | 20.09% |
| 2020 Q1 | 2.34 Million USD | -32.51% |
| 2020 Q2 | 2.12 Million USD | -9.27% |
| 2019 Q2 | 1.8 Million USD | 3.2% |
| 2019 Q3 | 2.27 Million USD | 25.75% |
| 2019 Q1 | 1.75 Million USD | -3.95% |
| 2019 FY | 9.29 Million USD | 63.97% |
| 2019 Q4 | 3.47 Million USD | 52.8% |
| 2018 Q2 | 1.69 Million USD | 111.24% |
| 2018 FY | 5.67 Million USD | 35.74% |
| 2018 Q4 | 1.82 Million USD | 34.46% |
| 2018 Q3 | 1.35 Million USD | -19.92% |
| 2018 Q1 | 801 Thousand USD | -62.2% |
| 2017 Q1 | 530 Thousand USD | 1258.97% |
| 2017 Q2 | 699 Thousand USD | 31.89% |
| 2017 Q3 | 828 Thousand USD | 18.45% |
| 2017 Q4 | 2.11 Million USD | 155.92% |
| 2017 FY | 4.17 Million USD | 1597.97% |
| 2016 Q1 | 163 Thousand USD | 640.91% |
| 2016 Q4 | 39 Thousand USD | 62.5% |
| 2016 Q2 | 20 Thousand USD | -87.73% |
| 2016 Q3 | 24 Thousand USD | 20.0% |
| 2016 FY | 246 Thousand USD | 67.35% |
| 2015 Q3 | 92 Thousand USD | 384.21% |
| 2015 Q4 | 22 Thousand USD | -76.09% |
| 2015 FY | 147 Thousand USD | 20.49% |
| 2015 Q1 | 14 Thousand USD | -82.28% |
| 2015 Q2 | 19 Thousand USD | 35.71% |
| 2014 Q1 | 14 Thousand USD | 12.57% |
| 2014 Q4 | 79 Thousand USD | 393.75% |
| 2014 Q3 | 16 Thousand USD | 23.08% |
| 2014 FY | 122 Thousand USD | 152.67% |
| 2014 Q2 | 13 Thousand USD | -7.14% |
| 2013 Q2 | 7373.00 USD | -52.97% |
| 2013 Q3 | 12.79 Thousand USD | 73.57% |
| 2013 FY | 48.28 Thousand USD | -79.54% |
| 2013 Q4 | 12.43 Thousand USD | -2.81% |
| 2013 Q1 | 15.67 Thousand USD | 186.3% |
| 2012 Q2 | 12.45 Thousand USD | -5.68% |
| 2012 Q3 | 8304.00 USD | -33.34% |
| 2012 FY | 236 Thousand USD | -78.95% |
| 2012 Q4 | 5476.00 USD | -34.06% |
| 2012 Q1 | 13.2 Thousand USD | 58.59% |
| 2011 FY | 1.12 Million USD | -50.07% |
| 2011 Q4 | 8328.00 USD | -95.88% |
| 2011 Q2 | 100.96 Thousand USD | -57.98% |
| 2011 Q1 | 240.27 Thousand USD | -23.37% |
| 2011 Q3 | 202 Thousand USD | 100.08% |
| 2010 Q2 | 2.16 Million USD | 10770.08% |
| 2010 Q4 | 313.56 Thousand USD | -32.76% |
| 2010 Q3 | 466.36 Thousand USD | -78.41% |
| 2010 FY | 2.24 Million USD | 76.84% |
| 2010 Q1 | 19.87 Thousand USD | -60.25% |
| 2009 Q4 | 49.99 Thousand USD | 221.53% |
| 2009 FY | 1.26 Million USD | 167.05% |
| 2009 Q1 | 278.52 Thousand USD | -23.59% |
| 2009 Q2 | 326.21 Thousand USD | 17.12% |
| 2009 Q3 | 15.54 Thousand USD | -95.23% |
| 2008 Q3 | 300.65 Thousand USD | 39.5% |
| 2008 Q1 | 60.89 Thousand USD | -54.73% |
| 2008 FY | 475.52 Thousand USD | 159.66% |
| 2008 Q4 | 364.49 Thousand USD | 21.23% |
| 2008 Q2 | 215.52 Thousand USD | 253.92% |
| 2007 Q1 | 22.68 Thousand USD | -73.36% |
| 2007 Q3 | 64.58 Thousand USD | 238.58% |
| 2007 Q2 | 19.07 Thousand USD | -15.92% |
| 2007 FY | 183.13 Thousand USD | -13.9% |
| 2007 Q4 | 134.51 Thousand USD | 108.28% |
| 2006 Q4 | 85.14 Thousand USD | 51.46% |
| 2006 Q3 | 56.21 Thousand USD | 10.18% |
| 2006 Q2 | 51.02 Thousand USD | 157.69% |
| 2006 Q1 | 19.8 Thousand USD | -64.32% |
| 2006 FY | 212.7 Thousand USD | -57.64% |
| 2005 Q2 | 119.25 Thousand USD | -0.71% |
| 2005 Q3 | 86.38 Thousand USD | -27.56% |
| 2005 Q1 | 120.1 Thousand USD | -50.36% |
| 2005 FY | 502.11 Thousand USD | 323.31% |
| 2005 Q4 | 55.49 Thousand USD | -35.77% |
| 2004 Q2 | -292.39 Thousand USD | -321.01% |
| 2004 Q4 | 241.94 Thousand USD | 1013.73% |
| 2004 Q1 | 132.3 Thousand USD | -13.38% |
| 2004 Q3 | 21.72 Thousand USD | 107.43% |
| 2004 FY | 118.61 Thousand USD | -86.05% |
| 2003 Q2 | 181.61 Thousand USD | -34.3% |
| 2003 FY | 850.57 Thousand USD | 30.06% |
| 2003 Q1 | 276.44 Thousand USD | 36.83% |
| 2003 Q3 | 125.97 Thousand USD | -30.64% |
| 2003 Q4 | 152.73 Thousand USD | 21.25% |
| 2002 Q1 | 121.32 Thousand USD | -35.0% |
| 2002 FY | 653.97 Thousand USD | -23.57% |
| 2002 Q4 | 202.04 Thousand USD | 6.08% |
| 2002 Q3 | 190.46 Thousand USD | -25.0% |
| 2002 Q2 | 253.96 Thousand USD | 109.32% |
| 2001 Q2 | 90.8 Thousand USD | -39.85% |
| 2001 Q3 | 92.03 Thousand USD | 1.36% |
| 2001 Q4 | 186.65 Thousand USD | 102.82% |
| 2001 FY | 855.66 Thousand USD | -45.41% |
| 2001 Q1 | 150.96 Thousand USD | -41.39% |
| 2000 Q3 | 356.33 Thousand USD | 4.13% |
| 2000 FY | 1.56 Million USD | -45.91% |
| 2000 Q2 | 342.19 Thousand USD | 47.14% |
| 2000 Q1 | 232.56 Thousand USD | -51.83% |
| 2000 Q4 | 257.56 Thousand USD | -27.72% |
| 1999 FY | 2.89 Million USD | -60.74% |
| 1999 Q4 | 482.83 Thousand USD | -5.29% |
| 1999 Q3 | 509.79 Thousand USD | -47.63% |
| 1999 Q2 | 973.36 Thousand USD | 98.27% |
| 1999 Q1 | 490.92 Thousand USD | -30.38% |
| 1998 Q1 | 2.75 Million USD | 5.73% |
| 1998 Q4 | 705.19 Thousand USD | -3.2% |
| 1998 Q3 | 728.5 Thousand USD | 85.43% |
| 1998 FY | 7.38 Million USD | 195.26% |
| 1998 Q2 | 392.88 Thousand USD | -85.73% |
| 1997 Q1 | 700 Thousand USD | 133.33% |
| 1997 Q2 | 900 Thousand USD | 28.57% |
| 1997 Q3 | 1.62 Million USD | 81.1% |
| 1997 Q4 | 2.6 Million USD | 59.81% |
| 1997 FY | 2.5 Million USD | 19.05% |
| 1996 Q2 | 800 Thousand USD | 33.33% |
| 1996 Q3 | 600 Thousand USD | -25.0% |
| 1996 FY | 2.1 Million USD | 0.0% |
| 1996 Q4 | 300 Thousand USD | -50.0% |
| 1996 Q1 | 600 Thousand USD | 50.0% |
| 1995 Q3 | 200 Thousand USD | 0.0% |
| 1995 Q4 | 400 Thousand USD | 100.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| BrainsWay Ltd. | 31.78 Million USD | 62.061% |
| Cerus Corporation | 156.36 Million USD | 92.288% |
| Envoy Medical, Inc. | 316 Thousand USD | -3716.139% |
| electroCore, Inc. | 16.03 Million USD | 24.772% |
| Helius Medical Technologies, Inc. | 644 Thousand USD | -1772.516% |
| IceCure Medical Ltd | 3.22 Million USD | -273.459% |
| Inogen, Inc. | 315.66 Million USD | 96.18% |
| OrthoPediatrics Corp. | 148.73 Million USD | 91.892% |
| Lucid Diagnostics Inc. | 2.42 Million USD | -396.664% |
| Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -3203.845% |
| MaxCyte, Inc. | 41.28 Million USD | 70.793% |
| NeuroOne Medical Technologies Corporation | 1.95 Million USD | -517.637% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -10788.684% |
| Orthofix Medical Inc. | 746.64 Million USD | 98.385% |
| PAVmed Inc | 2.45 Million USD | -391.803% |
| Rapid Micro Biosystems, Inc. | 22.51 Million USD | 46.45% |
| RxSight, Inc. | 89.07 Million USD | 86.462% |
| Sight Sciences, Inc. | 81.05 Million USD | 85.123% |
| SI-BONE, Inc. | 138.88 Million USD | 91.317% |
| TELA Bio, Inc. | 58.45 Million USD | 79.37% |
| Treace Medical Concepts, Inc. | 187.11 Million USD | 93.555% |
| Vivos Therapeutics, Inc. | 13.8 Million USD | 12.622% |
| Acutus Medical, Inc. | 7.16 Million USD | -68.328% |
| Talis Biomedical Corporation | 412 Thousand USD | -2826.942% |
| Spectral AI, Inc. | 18.05 Million USD | 33.213% |
| Nano-X Imaging Ltd. | 9.9 Million USD | -21.747% |
| CVRx, Inc. | 39.29 Million USD | 69.312% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 968.7 Thousand USD | -1144.857% |
| Bioventus Inc. | 512.34 Million USD | 97.646% |
| Venus Concept Inc. | 76.35 Million USD | 84.206% |
| TriSalus Life Sciences, Inc. | 18.51 Million USD | 34.855% |
| LivaNova PLC | 1.15 Billion USD | 98.955% |
| 908 Devices Inc. | 50.22 Million USD | 75.992% |
| Alphatec Holdings, Inc. | 482.26 Million USD | 97.499% |
| Nemaura Medical Inc. | 77.04 Thousand USD | -15552.095% |
| NeuroPace, Inc. | 65.42 Million USD | 81.567% |
| LENSAR, Inc. | 42.16 Million USD | 71.4% |
| Apyx Medical Corporation | 52.34 Million USD | 76.964% |
| Cutera, Inc. | 212.36 Million USD | 94.322% |
| STRATA Skin Sciences, Inc. | 33.35 Million USD | 63.85% |
| BioSig Technologies, Inc. | 18 Thousand USD | -66894.444% |
| Anika Therapeutics, Inc. | 166.66 Million USD | 92.764% |
| ClearPoint Neuro, Inc. | 23.95 Million USD | 49.66% |
| Integra LifeSciences Holdings Corporation | 1.54 Billion USD | 99.218% |
| Axonics, Inc. | 366.37 Million USD | 96.709% |
| Outset Medical, Inc. | 130.37 Million USD | 90.751% |
| IRIDEX Corporation | 51.86 Million USD | 76.751% |
| PROCEPT BioRobotics Corporation | 136.19 Million USD | 91.146% |
| IRadimed Corporation | 65.56 Million USD | 81.607% |
| Tivic Health Systems, Inc. | 1.17 Million USD | -925.425% |
| INVO Bioscience, Inc. | 3.02 Million USD | -299.229% |
| Telesis Bio, Inc. | 27.5 Million USD | 56.163% |
| Viemed Healthcare, Inc. | 183 Million USD | 93.411% |
| Varex Imaging Corporation | 811 Million USD | 98.513% |
| Quipt Home Medical Corp. | 221.74 Million USD | 94.562% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 68.67 Million USD | 82.44% |
| Dynatronics Corporation | 32.53 Million USD | 62.934% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 8.67 Million USD | -38.961% |
| Semler Scientific, Inc. | 68.18 Million USD | 82.314% |
| InMode Ltd. | 492.04 Million USD | 97.549% |
| Bruker Corporation | 2.96 Billion USD | 99.593% |
| Cytosorbents Corporation | 36.34 Million USD | 66.825% |
| DexCom, Inc. | 3.62 Billion USD | 99.667% |
| Align Technology, Inc. | 3.86 Billion USD | 99.688% |
| Viveve Medical, Inc. | 6.42 Million USD | -87.66% |
| ZimVie Inc. | 457.43 Million USD | 97.364% |
| Movano Inc. | - USD | -Infinity% |
| Cytek Biosciences, Inc. | 193.01 Million USD | 93.752% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -10788.684% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 747.71 Million USD | 98.387% |
| Profound Medical Corp. | 7.33 Million USD | -64.493% |
| Insulet Corporation | 1.69 Billion USD | 99.289% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 126.07 Million USD | 90.435% |
| iCAD, Inc. | 17.31 Million USD | 30.367% |
| Nuwellis, Inc. | 8.86 Million USD | -36.045% |
| Biotricity, Inc. | 12.06 Million USD | 0.036% |
| iRhythm Technologies, Inc. | 492.68 Million USD | 97.552% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 6.2 Million USD | -94.343% |
| PAVmed Inc. | 2.45 Million USD | -391.803% |
| BIOLASE, Inc. | 49.16 Million USD | 75.472% |
| Beyond Air, Inc. | 1.15 Million USD | -940.466% |
| FONAR Corporation | 102.88 Million USD | 88.279% |
| AxoGen, Inc. | 159.01 Million USD | 92.416% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 274.42 Million USD | 95.606% |
| Inari Medical, Inc. | 493.63 Million USD | 97.557% |
| UFP Technologies, Inc. | 400.07 Million USD | 96.986% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 18.6 Thousand USD | -64733.333% |
| Tenon Medical, Inc. | 2.92 Million USD | -311.851% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 6.81 Million USD | -77.025% |
| AdaptHealth Corp. | 3.2 Billion USD | 99.623% |
| Sintx Technologies, Inc. | 2.62 Million USD | -359.041% |
| NanoVibronix, Inc. | 2.28 Million USD | -428.208% |
| Quanterix Corporation | 122.36 Million USD | 90.145% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 24.4 Million USD | 50.588% |
| Pacific Biosciences of California, Inc. | 200.52 Million USD | 93.986% |
| TransMedics Group, Inc. | 241.62 Million USD | 95.009% |
| ReWalk Robotics Ltd. | 13.85 Million USD | 12.957% |
| NeuroMetrix, Inc. | 5.9 Million USD | -104.34% |
| Hyperfine, Inc. | 11.03 Million USD | -9.309% |
| Establishment Labs Holdings Inc. | 165.15 Million USD | 92.698% |
| Biomerica, Inc. | 5.41 Million USD | -122.696% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 50.56 Million USD | 76.15% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 177.13 Million USD | 93.192% |